8. Application of Pharmacogenetics in Dose Individualization in Diabetes, Psychiatry, Cancer and Cardiology.
作者信息
Tomalik-Scharte Dorota
机构信息
Department of Pharmacology, University of Cologne , Clinical Pharmacology Unit, Küln, Germany.
出版信息
EJIFCC. 2008 Apr 3;19(1):54-61. eCollection 2008 Apr.
Abstract
摘要
相似文献
1
8. Application of Pharmacogenetics in Dose Individualization in Diabetes, Psychiatry, Cancer and Cardiology.
EJIFCC. 2008 Apr 3;19(1):54-61. eCollection 2008 Apr.
2
Pharmacokinetic and Pharmacogenetic Markers of Irinotecan Toxicity.
Curr Med Chem. 2019;26(12):2085-2107. doi: 10.2174/0929867325666180622141101.
3
Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel.
Curr Med Chem. 2017;24(33):3559-3582. doi: 10.2174/0929867324666170623093445.
4
Pharmacogenetics for the individualization of psychiatric treatment.
Am J Pharmacogenomics. 2001;1(1):3-10. doi: 10.2165/00129785-200101010-00001.
5
Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism.
Curr Pharm Des. 2007;13(2):241-50. doi: 10.2174/138161207779313704.
6
[Pharmacogenetics in psychiatry: how far are we from clinical application?].
Vertex. 2012 Jul-Aug;23(104):299-309.
7
Individualized pharmacogenetic therapy: a critical analysis.
Community Genet. 2003;6(2):114-9. doi: 10.1159/000073007.
8
[Pharmacogenetics/pharmacogenomics in psychiatry].
Nihon Rinsho. 2010 Jan;68(1):155-62.
9
Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.
Pharmacogenomics. 2014 Dec;15(16):2063-82. doi: 10.2217/pgs.14.162.
10
Pharmacogenetics--genomics and personalized psychiatry.
Eur Psychiatry. 2010 Jun;25(5):291-3. doi: 10.1016/j.eurpsy.2009.12.015. Epub 2010 Apr 13.
本文引用的文献
1
The clinical role of genetic polymorphisms in drug-metabolizing enzymes.
Pharmacogenomics J. 2008 Feb;8(1):4-15. doi: 10.1038/sj.tpj.6500462. Epub 2007 Jun 5.
2
Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.
Clin Pharmacokinet. 2005;44(12):1209-25. doi: 10.2165/00003088-200544120-00002.
3
Pharmacogenetics-based therapeutic recommendations--ready for clinical practice?
Nat Rev Drug Discov. 2005 Aug;4(8):639-47. doi: 10.1038/nrd1801.
4
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
Mol Psychiatry. 2004 May;9(5):442-73. doi: 10.1038/sj.mp.4001494.
Zotero 插件